Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 10/20 | 0.46 |
| ▸ | CNR1 | P21554 | 2/20 | 0.39 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23802445 | 0.92 | CNR2 (0.46) | CNR2CNR1PLA2G2ANPC1 | |
| SCHEMBL23801788 | 0.90 | CNR2 (0.43) | CNR2CNR1PLA2G2ANPC1 | |
| SCHEMBL23801780 | 0.90 | CNR2 (0.43) | CNR2CNR1PLA2G2ANPC1 | |
| SCHEMBL23801343 | 0.89 | CNR2 (0.44) | CNR2CNR1PLA2G2ANPC1 | |
| SCHEMBL23801742 | 0.86 | CNR2 (0.42) | CNR2CNR1NPC1 | |
| SCHEMBL23802410 | 0.85 | CNR2 (0.41) | CNR2CNR1NPC1 | |
| SCHEMBL25515746 | 0.85 | CNR2 (0.38) | CNR2CNR1NPC1PLA2G4A | |
| SCHEMBL23802486 | 0.85 | CNR2 (0.42) | CNR2CNR1PLA2G2A | |
| SCHEMBL23801356 | 0.84 | CNR2 (0.40) | CNR2CNR1NPC1 | |
| SCHEMBL31346589 | 0.84 | CNR2 (0.40) | CNR2CNR1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
| WO-2021175855-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2021-09-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | OCIAD1, OCIAD2, OXER1 | CNR2 663/4885CNR1 878/4885PLA2G2A 4050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.